Invesco Health Care FundGTHRX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$1.1B
Expense ratio
1.32%
1-year return
—
3 years, a year
—
5 years, a year
—
Holdings
81
What it aims to do.
The Funds investment objective is long-term growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly and Co. | 9.65% |
| JNJ Johnson & Johnson | 5.85% |
| AZN AstraZeneca PLC | 4.18% |
| GILD Gilead Sciences, Inc. | 3.90% |
| UNH UnitedHealth Group Inc. | 3.79% |
| ARGX argenx SE | 3.66% |
| ABBV AbbVie Inc. | 3.62% |
| MCK McKesson Corp. | 3.43% |
| COR Cencora, Inc. | 3.12% |
| Invesco Private Prime Fund | 3.01% |
More on GTHRX.
- GTHRX overview
- GTHRX holdings
- GTHRX risk
- GTHRX costs
- GTHRX money in and out
- GTHRX share classes
- Compare GTHRX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.